Ancillary Symposium: Hypophosphatemia: Unlocking the Key to Improved Diagnosis and Management

This program is a 60-minute virtual webinar including live Q&A that will be available on-demand on Endocrine Society's Center for Learning platform.

This program was funded through educational grants from Horizon Therapeutics.

The live ancillary symposium and recording will include a pre-survey, post-assessment, evaluation, and follow-up survey, and will be certified for up to 1 AMA PRA Category 1 Credit and 1 ABIM MOC Point.

Registrants of this program prior to the event date will automatically be registered for the live symposium and will be sent login information 24-48 hours before the event. If you are unable to attend the live event, the recording will be available within 5-10 business days.

Additional Information

Target Audience: 
Clinical researcher
Scientific researcher
Nurse/Nurse practitioner
Physician assistant
Allied health professional
Competency Area: 
Patient Care and Procedural Skills
Medical Knowledge
Topic Area: 
General Endocrinology
Level of Outcomes: 
Level 1 (Participation)
Level 2 (Satisfaction)
Level 3A (Learning: Declarative Knowledge (Knows))
Activity summary
Course opens: 
Course expires: 


The clinical program will focus on clinical presentations on the state of care, challenges, and emerging therapies of Hypophosphatemia.

  • X-linked Hypophosphatemia Update: History and Future Goals of Treatment
  • Tumor-Induced Osteomalacia Diagnosis and Imaging
  • Tumor-Induced Osteomalacia Management and Therapeutic Goals
  • Patient Perspective
  • Audience Q&A with Patient and Expert Faculty

Michael A. Levine, MD
Chief Emeritus, Endo & Diabetes
Children's Hosp of Philadelphia
Philadelphia, PA

Leanne M. Ward, MD
Tier 1 Research Chair in Pediatric Bone Disorders
Professor of Pediatrics, University of Ottawa
Medical Director, The CHEO Genetic and Metabolic Bone Disease Clinic
Scientific Director, The Ottawa Pediatric Bone Health Research Group
Pediatric Endocrinologist, Division of Endocrinology and Metabolism
Children's Hospital of Eastern Ontario
Ottawa, Ontario 

The faculty, committee members, and staff who are in position to control the content of this activity are required to disclose to the Endocrine Society and to learners any relevant financial relationship(s) of the individual or spouse/partner that have occurred within the last 12 months with any commercial interest(s) whose products or services are related to the CME content. Financial relationships are defined by remuneration in any amount from the commercial interest(s) in the form of grants; research support; consulting fees; salary; ownership interest (e.g., stocks, stock options, or ownership interest excluding diversified mutual funds); honoraria or other payments for participation in speakers' bureaus, advisory boards, or boards of directors; or other financial benefits. The intent of this disclosure is not to prevent CME planners with relevant financial relationships from planning or delivery of content, but rather to provide learners with information that allows them to make their own judgments of whether these financial relationships may have influenced the educational activity with regard to exposition or conclusion.

The Endocrine Society has reviewed all disclosures and resolved or managed all identified conflicts of interest, as applicable.

The faculty reported the following relevant financial relationship(s) during the content development process for this activity:

  • Michael A. Levine, MD: Investigator, Ultragenyx Pharmaceuticals
  • Leanne M. Ward, MD : Clinical Trials, Ultragenyx Pharmaceuticals; Consultant, Ultragenyx Pharmaceuticals

The following SPC member who planned and reviewed content for this activity reported no relevant financial relationships:
Deborah Sellmeyer, MD

The following SPC Committee members reported relevant financial relationships:
Andjela T. Drincic, MD: Advisory Board Member, Corcept
Sergio Fazio, MD, PhD: Consultant, Amarin, Amgen, Akcea, Aegerion, Esperion, Novartis
Angela M. Leung, MD: Speaker, Medical Education Resources, MCE Conferences
Amy Rothberg, MD: Spouse, consultant of Merck

The Endocrine Society has reviewed these relationships to determine which are relevant to the content of this activity and resolved any identified conflicts of interest for these individuals.

The following SPC members reported no relevant financial relationships:
Katherine Araque, MD; Beret Ann Casey, MD; Jenny Blau, MD; Lorena Alarcon-Casas Wright, MD, Neena Natt, MD; Savitha Subramanian, MD; Soleymani Taraneh, MD; Steven Weitzman, MD

Click "Start" to complete the meeting evaluation, claim CME, and print a certificate of attendance or certificate of participation.

The Endocrine Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The Endocrine Society has achieved Accreditation with Commendation.  

The Endocrine Society designates each webinar will to be certified for up to 1 AMA PRA Category 1 Credits and 1 ABIM MOC Points. Physicians should claim only the credit commensurate with the extent of their participation in the activity.   For questions about content or obtaining CME credit, please contact the Endocrine Society at 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program, for each webinar. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. 

In order to earn and report MOC points to the American Board of Internal Medicine (ABIM), you must:

  1. Provide your board-certification information in your educational profile.  Your profile currently contains the following board ID numbers (must be logged in to view):
    Your ABIM Number: [current-user:profile-profile:field-number-abim]*

    *If your ABIM number is blank or incorrect as shown above, please click the Update Profile button below to add or correct your profile.
  2. Update Profile

Registration is complimentary and open to anyone with Endocrine Society login credentials. You can select to add this symposium to an existing EBR and/or CEU registration or register for it as a standalone event.

We thank Ultragenyx Pharmaceuticals for supporting this program